Novartis International AG /
Novartis announces data show majority of patients with polycythemia vera treated
with Jakavi® achieved long-term disease control
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
...
↧